Pharmacological Reports , 2018 Neurological and NO Pathway Regulation: Emerging data suggests that BPC-157 may modulate nitric oxide (NO) and dopamine systems, which could explain its potential for nerve regeneration and mood regulationthough lower doses may be more appropriate for systemic neurological use
Phase I data presented at the American Heart Association (AHA) 2025 meeting and published in The New England Journal of Medicine ( NEJM ) showed deep, dose-dependent reductions in ANGPTL3 (up to 89%) with corresponding decreases in triglycerides and LDL cholesterol, including in patients already on standard lipid-lowering therapy
Marked improvements in lipid profile and blood pressure were also observed compared to placebo [81]
Anyone on a plant-based diet who has not yet checked their B12 status is a candidate for either a supplement or an injection
Quick reference comparing this retatrutide and cagrilintide kit with three related research peptides by primary mechanism, research application, and form
For an introduction to our Peptide & Regenerative Medicine Performance Team, email [email protected] and well point you in the right direction.